Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography
- PMID: 2065264
- DOI: 10.1002/1097-0142(19910801)68:3<458::aid-cncr2820680303>3.0.co;2-3
Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography
Abstract
From November 1987 to January 1991, 1300 postmenopausal women underwent screening with transvaginal sonography (TVS). Women eligible for screening were all asymptomatic with no known ovarian tumors. Ovarian volume was calculated using the prolate ellipsoid formula, and a value in excess of 8.0 cm3 was considered abnormal. Ovarian abnormalities were detected in 33 women (2.5%), and 27 underwent exploratory laparotomy. Ovarian tumors were noted in all 27 patients, including 2 primary carcinomas and 14 serous cystadenomas. The two women with ovarian carcinomas had normal results of pelvic examinations and normal serum CA-125 levels. Both women had Stage I disease, and are alive and well after conventional therapy. TVS was time efficient, easy to perform, and well-accepted by patients. Currently, there are more than 3000 patient years of follow-up in the screened population, and there have been no deaths due to ovarian cancer. A multi-institutional trial to determine the efficacy of TVS as a screening method for ovarian cancer is indicated.
Similar articles
-
Ovarian cancer screening in asymptomatic postmenopausal women.Gynecol Oncol. 1993 Nov;51(2):205-9. doi: 10.1006/gyno.1993.1273. Gynecol Oncol. 1993. PMID: 8276295
-
Transvaginal sonography as a screening method for the detection of early ovarian cancer.Gynecol Oncol. 1997 Jun;65(3):408-14. doi: 10.1006/gyno.1997.4705. Gynecol Oncol. 1997. PMID: 9190966 Review.
-
Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened.Cancer. 1990 Feb 1;65(3):573-7. doi: 10.1002/1097-0142(19900201)65:3<573::aid-cncr2820650331>3.0.co;2-4. Cancer. 1990. PMID: 2404560
-
Ovarian cancer screening.Cancer. 1995 Nov 15;76(10 Suppl):2086-91. doi: 10.1002/1097-0142(19951115)76:10+<2086::aid-cncr2820761330>3.0.co;2-l. Cancer. 1995. PMID: 8635005 Review.
-
The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.Gynecol Oncol. 2000 Jun;77(3):350-6. doi: 10.1006/gyno.2000.5816. Gynecol Oncol. 2000. PMID: 10831341 Clinical Trial.
Cited by
-
Forth nightly review: hereditary ovarian carcinoma.BMJ. 1999 Mar 20;318(7186):786-9. doi: 10.1136/bmj.318.7186.786. BMJ. 1999. PMID: 10082707 Free PMC article. Review. No abstract available.
-
Treatment of ovarian cancer: the state of the art.Med Oncol Tumor Pharmacother. 1993;10(3):139-42. doi: 10.1007/BF02987781. Med Oncol Tumor Pharmacother. 1993. PMID: 8264259 Review.
-
Screening for ovarian cancer.BMJ. 1993 Apr 17;306(6884):1015-6. doi: 10.1136/bmj.306.6884.1015. BMJ. 1993. PMID: 8369042 Free PMC article. No abstract available.
-
Prophylactic oophorectomy in Ontario.Fam Cancer. 2001;1(3-4):143-8. doi: 10.1023/a:1021174604905. Fam Cancer. 2001. PMID: 14574170
-
Clinical and ultrasound characteristics of virilizing ovarian tumors in pre- and postmenopausal patients: a single tertiary center experience.Orphanet J Rare Dis. 2021 Oct 12;16(1):426. doi: 10.1186/s13023-021-02057-z. Orphanet J Rare Dis. 2021. PMID: 34641931 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous